Transfemoral TAVI using the self-expanding ACURATE neo prosthesis: one-year outcomes of the multicentre “CE-approval cohort”

EuroIntervention 2017;13:e1040-e1046 published online August 2017 published online e-edition October 2017. DOI: 10.4244/EIJ-D-17-00187

Helge Möllmann
Helge Möllmann1,2*, MD; Thomas Walther3, MD; Dimytri Siqueira4, MD; Patrick Diemert5, MD; Hendrik Treede6, MD; Eberhard Grube7, MD; Georg Nickenig7, MD; Stephan Baldus8, MD; Tanja Rudolph8, MD; Toru Kuratani9, MD; Yoshiki Sawa10, MD; Joerg Kempfert3,11, MD; Won-Keun Kim1,3, MD; Alexandre Abizaid4,12, MD
1. Department of Cardiology, Kerckhoff Heart and Lung Center, Bad Nauheim, Germany; 2. Department of Internal Medicine-I, Cardiology, St. Johannes-Hospital, Dortmund, Germany; 3. Department of Cardiac Surgery, Kerckhoff Heart and Lung Center, Bad Nauheim,

Aims: The aim of this study was to assess the safety and performance of the ACURATE neo transcatheter heart valve and its transfemoral delivery system.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

aortic stenosisdeathfemoralstroketranscatheter aortic valve implantation
Read next article
Transcatheter mitral valve replacement: long-term outcomes of first-in-man experience with an apically tethered device– a case series from a single centre

Latest news